key: cord-1016160-t9m84bjt authors: Lee, Wonwoo; Lee, Chang Hyung; Lee, Jungkyu; Jeong, Yoonseon; Park, Jong-Hyung; Nam, In-Jeong; Lee, Doo Suk; Lee, Hyun Myung; Lee, Jaehyun; Yun, Nayoung; Song, Jisun; Choi, Sooyeon; Kim, Sunyoung title: Botanical formulation, TADIOS, alleviates lipopolysaccharide (LPS)-Induced acute lung injury in mice via modulation of the Nrf2-HO-1 signaling pathway date: 2021-04-24 journal: J Ethnopharmacol DOI: 10.1016/j.jep.2021.113795 sha: f8521f64189c9f10946d1f49aaa16d1a752f0efd doc_id: 1016160 cord_uid: t9m84bjt ETHNOPHARMACOLOGICAL RELEVANCE: TADIOS is an herbal formulation prepared from a mixture of Taraxacum officinale (L.) Weber ex F.H.Wigg, Dioscorea batatas Decaisne and Schizonepeta tenuifolia (Benth.) Briquet. These plants have traditionally been used in Asia to treat a variety of respiratory diseases. A bulk of literature on traditional Korean medicine describe their activities and functions for respiratory problems. Therefore, we hypothesized that the combination of these plants might be effective in alleviating respiratory symptoms. AIM OF THE STUDY: In this study, we investigated whether TADIOS ameliorates LPS-induced acute lung injury via regulation of the Nrf2-HO-1 signaling pathway. MATERIALS AND METHODS: The LPS-induced acute lung injury mouse model was used to determine the anti-inflammatory and anti-oxidative stress effects of TADIOS. The amount of marker compounds contained in TADIOS was quantified using high-performance liquid chromatography (HPLC) analysis. The protein level of pro-inflammatory cytokines in culture supernatant was measured by ELISA. Changes in the RNA level of pro-inflammatory cytokines in mice lungs and RAW264.7 cells were measured by quantitative RT-PCR. The relative amounts of reactive oxygen species (ROS) were measured by DCF-DA assay. Western blot analysis was used to evaluate expression of cellular proteins. Effects of TADIOS on antioxidant responsive elements (AREs) were determined by luciferase assay. The severity of acute lung injury was evaluated by Hematoxylin & Eosin (H&E) staining. To test the effects of TADIOS on LPS-induced oxidative stress, myeloperoxidase (MPO) activity and the total antioxidant capacity were measured. RESULTS: TADIOS was prepared by extraction of a blend of these three plants by ethanol, and quality control was performed through quantification of marker compounds by HPLC and measurement of bioactivities using cell-based bioassays. In the murine macrophage cell line RAW264.7, TADIOS effectively suppressed the production of pro-inflammatory cytokines such as IL-6 and IL-1β, and also ROS induced by LPS. When RAW264.7 cells were transfected with a luciferase reporter plasmid containing nucleotide sequences for AREs, TADIOS treatment increased the level of relative luciferase units in a dose-dependent manner. In the LPS-induced acute lung injury mouse model, orally administered TADIOS alleviated lung damage and neutrophil infiltration induced by LPS. Consistent with the in vitro data, treatment with TADIOS inhibited the LPS-mediated expression of pro-inflammatory cytokines and oxidative stress, and activated the Nrf2-HO-1 axis. CONCLUSION: Our data suggest the potential for TADIOS to be developed as a safe and effective therapeutics for the treatment of acute respiratory distress syndrome. Botanical formulation, TADIOS, alleviates lipopolysaccharide (LPS)-Induced acute lung injury in mice via modulation of the Nrf2-HO-1 signaling pathway Wonwoo Lee *,1 , Chang Hyung Lee 1 , Jungkyu Lee, Yoonseon Jeong, Doo Suk Lee, Hyun Myung Lee, Jaehyun Lee, Nayoung Yun, Jisun Song, Sooyeon Choi, Sunyoung Kim R&D Center for Innovative Medicines, Helixmith Co., Ltd., Seoul, 07794 Ethnopharmacological relevance: TADIOS is an herbal formulation prepared from a mixture of Taraxacum officinale (L.) Weber ex F.H.Wigg, Dioscorea batatas Decaisne and Schizonepeta tenuifolia (Benth.) Briquet. These plants have traditionally been used in Asia to treat a variety of respiratory diseases. A bulk of literature on traditional Korean medicine describe their activities and functions for respiratory problems. Therefore, we hypothesized that the combination of these plants might be effective in alleviating respiratory symptoms. Aim of the study: In this study, we investigated whether TADIOS ameliorates LPS-induced acute lung injury via regulation of the Nrf2-HO-1 signaling pathway. Materials and methods: The LPS-induced acute lung injury mouse model was used to determine the antiinflammatory and anti-oxidative stress effects of TADIOS. The amount of marker compounds contained in TADIOS was quantified using high-performance liquid chromatography (HPLC) analysis. The protein level of pro-inflammatory cytokines in culture supernatant was measured by ELISA. Changes in the RNA level of proinflammatory cytokines in mice lungs and RAW264.7 cells were measured by quantitative RT-PCR. The relative amounts of reactive oxygen species (ROS) were measured by DCF-DA assay. Western blot analysis was used to evaluate expression of cellular proteins. Effects of TADIOS on antioxidant responsive elements (AREs) were determined by luciferase assay. The severity of acute lung injury was evaluated by Hematoxylin & Eosin (H&E) staining. To test the effects of TADIOS on LPS-induced oxidative stress, myeloperoxidase (MPO) activity and the total antioxidant capacity were measured. Results: TADIOS was prepared by extraction of a blend of these three plants by ethanol, and quality control was performed through quantification of marker compounds by HPLC and measurement of bioactivities using cellbased bioassays. In the murine macrophage cell line RAW264.7, TADIOS effectively suppressed the production of pro-inflammatory cytokines such as IL-6 and IL-1β, and also ROS induced by LPS. When RAW264.7 cells were transfected with a luciferase reporter plasmid containing nucleotide sequences for AREs, TADIOS treatment increased the level of relative luciferase units in a dose-dependent manner. In the LPS-induced acute lung injury mouse model, orally administered TADIOS alleviated lung damage and neutrophil infiltration induced by LPS. Consistent with the in vitro data, treatment with TADIOS inhibited the LPS-mediated expression of proinflammatory cytokines and oxidative stress, and activated the Nrf2-HO-1 axis. Conclusion: Our data suggest the potential for TADIOS to be developed as a safe and effective therapeutics for the treatment of acute respiratory distress syndrome. Acute respiratory distress syndrome (ARDS) is the most common cause of severe respiratory failure triggered by damage to the alveoli and capillary barrier (Gonzales et al., 2015) . ARDS occurs in the United States at a rate of 0.065-0.08%, with 75% of cases categorized as moderate or severe (Diamond et al., 2020) . The case fatality rate from mild to severe ARDS stands at approximately 27-45%, which is significantly higher than for other acute/chronic diseases such as myocardial infarction, pneumonia, and asthma (Diamond et al., 2020) . The causative infectious agent SARS-CoV-2 (Fan et al., 2020; Gibson et al., 2020; Li and Ma, 2020) at the heart of the COVID-19 pandemic has escalated the threat of ARDS from a major healthcare concern to a global crisis. Excessive inflammation of the airway induced by inhalation of virulent substances into the bronchi is thought to be important in the pathogenesis of ARDS (Han and Mallampalli, 2015) . Only symptomatic relief therapies are currently available, such as inhaled nitric oxide (iNO) or corticosteroids (Gebistorf et al., 2016; Khilnani and Hadda, 2011) . However, the efficacy and safety of these treatments remain inadequate and there is a high unmet medical need for a fundamental treatment for ARDS (Patel et al., 2018) . LPS-induced acute lung injury (ALI), an animal model of severe pulmonary inflammation, has been extensively used to study ARDS Rittirsch et al., 2008) . Intratracheal injection of LPS stimulates alveolar macrophages' rapid production of proinflammatory cytokines like TNF-α, IL-6 and IL-1β, which induce the infiltration and activation of neutrophils (Bosmann et al., 2013; Chen et al., 2020; Chignard and Balloy, 2000; de Souza Xavier Costa et al., 2017; Rittirsch et al., 2008) . Stimulated neutrophils then produce a large quantity of ROS and cytokines, which further aggravate severe lung damage through destructive inflammatory responses (Dong and Yuan, 2018; Lee, H.R. et al., 2019; Potey et al., 2019) . These are also the pathogenic characteristics of infection with SARS-CoV-2 (Delgado-Roche and Mesta, 2020; Kong et al., 2020; Laforge et al., 2020; Wang et al., 2020) . The nuclear factor erythroid 2-related factor 2 (Nrf2) is one of the major regulators of cellular defense against oxidative stress (Ma, 2013; Vomund et al., 2017) . Under oxidative-stress conditions, Nrf2 binds to AREs, initiating the transcription of a family of cytoprotective genes that include heme oxygenase-1 (HO-1) (Jeong et al., 2019; Loboda et al., 2016) . This Nrf2-induced anti-oxidative stress enzyme scavenges excessive ROS and inhibit inordinate inflammatory responses Zhao et al., 2017) . ARDS is an acute lung disease with several causes that encompasses various cellular factors along the pathogenic progress and results in multiple types of damage to tissues (Matthay and Zemans, 2011; Sharp et al., 2015) . We hypothesized that herbs and/or their extracts might be used as starting materials for developing more effective therapeutic agents for ARDS since they contain multiple compounds with health benefits. Many such therapeutic extracts have been extensively documented for their safety and efficacy, and contain a variety of chemical compounds that may regulate the cellular or biochemical entities involved in the pathogenesis of ARDS (Chen et al., 2018; Dai et al., 2014; Han et al., 2013; Huang et al., 2018) . Based on the literature on traditional Korean medicine describing their activities and functions, three plants were chosen for our study: Dioscorea batatas Decaisne, Taraxacum officinale (L.) Weber ex F.H.Wigg and Schizonepeta tenuifolia (Benth.) Briquet. In Korea, they are all classified as dietary ingredients. Dioscorea batatas Decaisne is known to have the lung-nourishing and cough relieving properties (Kang B, 2000; Ma et al., 2018; Min-Hye Yang, 2009) . It has been shown to contain anti-oxidant and anti-inflammatory activities, and inhibit PM 2.5 -induced lung injury, whose pathological phenotypes are similar to ARDS (Lee, W. et al., 2019a) . Taraxacum officinale (L.) Weber ex F.H.Wigg has traditionally been used to treat respiratory problems, including sore throat and lung abscess (Hee-Jung Ha, 2011; Kang B, 2000) . A water-soluble extract from Taraxacum officinale (L.) Weber ex F.H.Wigg has been reported to inhibit LPS-induced ALI via regulation of oxidative stress-and inflammation-related responses (Liu et al., 2010) . Schizonepeta tenuifolia (Benth.) Briquet is widely prescribed in Korea for a variety of respiratory infections such as the common cold, fever, and sore throat (Fujita and Fujita, 1973; Fung and Lau, 2002; Kang B, 2000) . It was reported that Schizonepeta tenuifolia (Benth.) Briquet suppresses pulmonary inflammation by regulating the TLR4 signaling pathway (Byun, 2014) . Since the aforementioned plants are typically taken in an ethanol extracted form, this study combined the three plants followed by ethanol extraction, to generate TADIOS (also called HX110B) (Lee et al., 2020) . The LPS-induced ALI mouse model was then used to evaluate the therapeutic and preventative effects of TADIOS. TADIOS was much more effective in suppressing the inflammatory responses induced by LPS than the individual plant extracts. When the murine macrophage cell line RAW264.7 was employed to understand the underlying mechanisms for these responses, TADIOS was found to activate the axis of the Nrf2-HO-1 signaling pathway. Data obtained from TADIOS-treated mouse experiments were highly comparable to above in vitro results. These results indicated that TADIOS might be developed as an effective and safe therapeutics to alleviate clinical condition associated with ARDS. Batch-to-batch consistency was monitored by quantifying marker compounds via HPLC analysis. Representative marker compounds for each plant (allantoin (Sigma-Aldrich, St. Louis, MO, USA) for Dioscorea batatas Decaisne, chicoric acid (Sigma-Aldrich, St. Louis, MO, USA) for Taraxacum officinale (L.) Weber ex F.H.Wigg and luteolin-3 ′ -glucuronide (Chengdu biopurify, Chengdu, Sichuan, China) for Schizonepeta tenuifolia (Benth.) Briquet) were selected based on previously published information (Cai et al., 2020; Kajla et al., 2017; Wang et al., 2017) . Standard solutions of representative markers were prepared by dissolving their reference compounds in 50% methanol and filtered with a 0.45 μm PVDF filter before use. Sample solutions of the extracts were also prepared in the same manner. HPLC analysis was performed using Waters Alliance 2695 HPLC system coupled with UV detector (Waters, Millford, MA, USA). Details on the conditions of HPLC analysis can be found in Table S1 . All experimental procedures were conducted in compliance with the guidelines set by the Institutional Animal Care and Use Committee of Helixmith Co., Ltd. Male C57BL/6 mice at seven weeks of age were purchased from Raonbio Inc. (Yongin, Korea). All mice were housed for 1 week to adapt to their surroundings before surgery in an airconditioned facility under a fixed 12-h light/dark cycle. All animal experiments were carried out in accordance with the Guide for Animal Experimentation of Helixmith Co., Ltd. The protocol was approved by the Institutional Animal Care and Use Committee of Helixmith Co., Ltd (Approval Number: VIC-20-11-001). Male C57BL/6 (8-week-old) mice were divided into 7 groups as follows (n = 8 per group): i) normal control (NC) group; ii) LPS group; iii) Dioscorea batatas Decaisne (500 mg/kg) group; iv) Taraxacum officinale (L.) Weber ex F.H.Wigg (500 mg/kg) group; v) Schizonepeta tenuifolia (Benth.) Briquet (500 mg/kg) group; vi) TADIOS (500 mg/kg) group; and vii) TADIOS (1000 mg/kg) group. Extracts of individual plants were dissolved with distilled water and administered orally 1 h prior to the intratracheal injection of LPS (2 mg/kg, dissolved with PBS). Twenty-four hours after the LPS injection, animals were sacrificed using carbon dioxide and isolated lungs were subjected to Hematoxylin & Eosin (H&E) staining. Mouse lungs were fixed in 10% normalized buffered formalin (Sigma-Aldrich, St. Louis, MO, USA) and embedded in a paraffin block. Then, 6-μm paraffin sections of the lungs were stained with H&E to visualize tissue areas. Lungs were lavaged with 0.7 mL PBS through the cannulated trachea. The BALF obtained was centrifuged at 1500 rpm for 5 min at 4 • C to separate the supernatant from the cells. Cell pellets were counted in a hemocytometer and H&E-stained to identify the differential profiles after cytospin preparation. Total cells and neutrophils were counted via light microscope (Olympus, Tokyo, Japan) according to morphological criteria and staining. The antioxidant enzymatic activities were measured using Total antioxidant capacity (TAC) assay kit (DoGen, Seoul, Korea) and myeloperoxidase (MPO) assay kit (Sigma-Aldrich, St. Louis, MO, USA) according to the manufacturers' protocol. Quantification of total proteins was performed using a Bradford protein assay reagent (Invitrogen, Carlsbad, CA, USA). The lung tissue was homogenized with T-per tissue extraction reagent (ThermoFisher, Waltham, MA, USA) and mixed with PhosSTOP™ and cOmplete™ Protease Inhibitor Cocktail (Roche, Basel, Switzerland) for 20 min on ice. The cell extracts were prepared using RIPA buffer (Sigma-Aldrich, St. Louis, MO, USA) containing protease inhibitors. The tissue and cell homogenates were then centrifuged at 12,000 g for 15 min and the supernatant was collected. The total protein in the lung tissue was quantified by the Bradford protein assay reagent (Invitrogen, Carlsbad, CA, USA). After reconstituting in sample buffer, protein samples were subjected to SDS-PAGE on Bolt™ 10% Bis-Tris Plus Gels (Invitrogen, Carlsbad, CA, USA). Proteins were transferred onto a polyvinylidene difluoride (PVDF) membrane (Millipore, MA, USA) using Power Blotter Station system (Invitrogen, Carlsbad, CA, USA) and the membrane was incubated in 5% skim milk in 0.1% TBST at room temperature for 1 h to block nonspecific binding. The membrane was then incubated with antibodies specific to HO-1 (#70081), Nrf2 (#12721; Cell signaling, Beverly, MA, USA) and β-actin (A5441, Sigma-Aldrich, St. Louis, MO, USA) overnight at 4 • C followed by incubation with horseradish peroxidase-conjugated secondary anti-mouse or anti-rabbit IgG (1:100,000; Sigma-Aldrich, St. Louis, MO, USA) at room temperature for 1 h. The blot was developed by Immobilon ECL HRP substrate (Millipore, MA, USA) and visualized by ChemiDoc MP imaging system (BIO-RAD, CA, USA). The RAW264.7 cell line was purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in RPMI1640 medium (Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine serum (FBS; Invitrogen, Carlsbad, CA, USA), 100 U/ml penicillin and 100 μg/mL streptomycin. LPS and OB-24 were purchased from Sigma-Aldrich (St. Louis, MO, USA). siNrf2 was purchased from Invitrogen (Carlsbad, CA, USA). IL-6 and IL-1β in cell culture supernatants were measured using commercially available ELISA kits (R&D systems, Minneaplis, MN). Both mouse lung and cell line RNAs were obtained using Trizol reagent (Invitrogen, Carlsbad, CA, USA). cDNA was synthesized using oligo dT primers (QIAGEN, Valencia, USA) and Reverse Transcriptase XL (avian myeloblastosis virus (AMV)) (Takara, Shiga, Japan) from 1 μg of RNA. Real-time quantitative RT-PCR was performed with SYBR Premix (Takara, Shiga, Japan) and Thermal Cycler Dice Real Time System TP800 (Takara, Shiga, Japan). PCR conditions were denaturation at 95 • C for 5 s, followed by annealing and extension at 60 • C for 30 s. The sequences of synthesized PCR primer (Bioneer Co. Ltd., Seoul, Korea) are presented in Table 1 . A Griess Reagent Kit (Invitrogen, Carlsbad, CA, USA) was used to measure NO. Briefly, the level of nitrite was measured by adding 100 μL of Griess reagent to 50 μL of culture supernatant. The optical density at 550 nm was measured with a microplate reader and then determined from a sodium nitrite standard curve. ROS production was quantified using a DCF-DA ROS detection reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. A WST-1 assay Kit (DoGen, Seoul, Korea) was used to measure cell viability. Briefly, RAW264.7 cells were cotreated with LPS and different concentrations of TADIOS for 24 h, followed by the addition of WST-1 reagent. After 1 h, the cell viability was determined by measuring the OD at 450 nm using a microplate reader (ThermoFisher, Waltham, MA, USA). An inducible AREs-responsive luciferase reporter assay kit was purchased from QIAGEN (Valencia, USA), and the assay was performed as described before (Lee, W. et al., 2019b; Lee et al., 2018a; Lee et al., 2018b) . RAW264.7 cells were briefly transfected with either ARE-reporter plasmid or negative control plasmid using lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA). Twenty-four hours after transfection, the cells were treated first with various concentrations of TADIOS for 30 min, then with LPS (100 ng/mL) for 18 h. Cell lysates were prepared and a luciferase activity assay was performed using the dual luciferase reporter assay system (Promega, Madison, WI, USA) and Varioskan LUX (ThermoFisher, Waltham, MA, USA) according to the manufacturer's protocol. The siRNA specific to Nrf2 and scrambled siRNA (ThermoFisher, Waltham, MA, USA) were transfected into RAW264.7 cells using RNAiMAX (ThermoFisher, Waltham, MA, USA). Twenty-four hours after the siRNA-induced knockdown of Nrf2, cells were treated with LPS and TADIOS and then subjected to further experiments. Knockdown efficiency was tested using an antibody against Nrf2 (1:1000, Cell signaling, Beverly, MA, USA). All values are represented as mean ± S.E.M. of three independent experiments. Statistical significance was determined using unpaired Student's t-test or one-way ANOVA with Tukey correction, provided by the GraphPad Prism software version 7 (GraphPad, USA). The F statistic values of the ANOVA tests were presented in Table S2 . Data were considered statistically significant if the p-value was <0.05. TADIOS, the botanical extract composed of 3 plants, was tested for its effects on LPS-induced inflammatory responses in this model. First, TADIOS was compared to the effects of individual plant extracts from Dioscorea batatas Decaisne, Taraxacum officinale (L.) Weber ex F.H.Wigg and Schizonepeta tenuifolia (Benth.) Briquet. As Fig. 1 shows, the expression of pro-inflammatory cytokines increased dramatically in the LPS-treated group, while extracts from individual plants did not have significant effects. However, TADIOS treatment lowered the RNA level of TNF-α, IL-6 and IL-1β in a statistically significant manner. The content of each marker compound contained in TADIOS was quantified using HPLC analysis in order to verify the batch-to-batch consistency ( Fig. 2A and B ). The measured values from the three batches used in this study are shown in Fig. 2C . The quantity of respective marker compounds has been highly consistent from batch to batch. In addition, the quality of TADIOS was also biologically controlled using cell-based bioassays. The effect of TADIOS on nitric oxide production was measured to determine the half maximal inhibitory concentration (IC 50 ) value (Fig. 2D) . Only TADIOS batches showing IC 50 values between 0.3 and 0.6 mg/mL were used in the experiments. We investigated the anti-inflammatory effects of TADIOS in RAW264.7 cells. As shown in Fig. 3A , the nitric oxide production induced by LPS was significantly reduced by TADIOS treatment in a dose-dependent manner. We then tested the capacity of TADIOS to inhibit the LPS-induced production of pro-inflammatory cytokines. Cells treated exclusively with LPS showed highly increased production levels of IL-6 and IL-1β, but TADIOS cotreatment inhibited such LPS effects in a dose-dependent manner ( Fig. 3B and C) . Interestingly, the LPS-induced production of TNF-α was not affected, likely due to the specific characteristics of this particular murine macrophage cell line as previously reported by Choi et al. (2012) . To test the effect of TADIOS on the RNA level of these proinflammatory cytokines, quantitative RT-PCR was performed. Consistent with protein results, TADIOS treatment significantly reduced the RNA levels of IL-6 and IL-1β, but not of TNF-α ( Fig. 3D and E) . To ascertain that this TADIOS-mediated inhibition of pro-inflammatory gene expression was not related with the cytotoxic effects of the reagents used in the study, the effects of LPS and TADIOS on cell viability were determined using WST-1 assay. Under our experimental conditions, no significant cytotoxic effects were observed (Fig. 3F) . We investigated the effects of TADIOS on the ROS production. As shown in Fig. 4A , the LPS-induced production of ROS was inhibited by TADIOS in a dose-dependent manner. To test the effects of TADIOS on the expression of HO-1, Western blot and quantitative RT-PCR analyses were performed. In these experiments, TADIOS treatment increased the HO-1 protein levels in a dose- Table 1 Primer sequences. (Fig. 4B) . RNA levels of HO-1 were consistently enhanced by TADIOS in a dose-dependent manner (Fig. 4C) . To test whether TADIOS can suppress the ROS production through the regulation of HO-1, HO-1 inhibitor OB-24 was used. OB-24 treatment effectively blocked TADIOS-mediated inhibition of ROS production (Fig. 4D) . Since Nrf2 is well-known to regulate the expression of HO-1, we tested whether TADIOS could control the Nrf2 signaling pathway using a luciferase reporter plasmid. As shown in Fig. 5A , TADIOS treatment increased the relative luciferase units in a dose-dependent manner. To further study the role of Nrf2 in the TADIOS-mediated induction of HO-1, changes in the protein levels of Nrf2 were analyzed. Levels of the Nrf2 protein were very low under normal and LPS-treated conditions, but increased with TADIOS treatment in a dose-dependent manner (Fig. 5B) . To validate the causative relationship, Nrf2-specific siRNA was used. The protein levels of Nrf2 were very low when cells were transfected with siRNA specific to Nrf2 (Fig. 5C ). TADIOS treatment greatly raised the expression levels of HO-1 in cells transfected with control siRNA, whereas this effect was much lower in cells transferred with Nrf2 siRNA (Fig. 5D ). Based on the above in vitro data, we investigated the possibility that TADIOS might regulate pulmonary inflammation in LPS-induced ALI mouse model. In mice treated with LPS alone, significant changes in histopathology were observed due to this endotoxin-mediated inflammation of the lungs, including a manifest inflammatory cell infiltration and thickening of the alveolar wall, compared with those of control mice ( Fig. 6A and B) . However, TADIOS treatment effectively ameliorated the LPS-induced pathological changes in a dose-dependent manner ( Fig. 6C and D) . Next, the effects of TADIOS were tested on inflammatory cell infiltration. As shown in Fig. 6E , LPS treatment significantly increased the number of total cells and neutrophils in the BALF, but it was decreased in a dose-dependent manner when mice were administered with TADIOS ( Fig. 6F and G) . To unravel the molecular mechanisms of TADIOS, the effects on a variety of inflammation-related genes in control group animals were compared to TADIOS-treated mice. Twenty-four hours after exposure to vehicle or LPS, the RNA level of pro-inflammatory cytokines was highly increased by LPS treatment, while this effect was markedly inhibited when mice were administered with TADIOS (Fig. 7A) . To test the effects of TADIOS on LPS-induced oxidative stress, MPO activity and the total antioxidant capacity in mice lungs were measured 24 h after the LPS challenge. When mice were treated with LPS alone, the levels of MPO activity and of antioxidants were changed as expected, but returned to normal levels upon treatment with TADIOS (Fig. 7B ). Based on in vitro data, effect of TADIOS on the Nrf2-HO-1 signaling pathway was tested in this mouse model. As presented in Fig. 7C , LPSmediated reduction of the HO-1 and Nrf2 proteins was suppressed by TADIOS treatment in a dose-dependent manner. In this study, we developed the plant formulation, TADIOS, an ethanol extract from a blend of three herbs (Taraxacum officinale (L.) Weber ex F.H.Wigg, Dioscorea batatas Decaisne and Schizonepeta tenuifolia (Benth.) Briquet). We demonstrated that TADIOS was highly effective in regulating inflammation and oxidative stress both in vivo and in vitro experiments, and alleviating the pathologic features of acute lung injury caused by the intratracheal injection of LPS. It was shown that the combined use of the three plants more effectively inhibited the expression of proinflammatory cytokines, TNF-α, IL-6 and IL-1β than singlesource extracts from individual plants. In RAW264.7 cells, TADIOS was shown to suppress the LPS-induced ROS production through activation of Nrf2-HO-1 signaling pathway, all in a dose-dependent manner. In the LPS-induced lung injury mouse model, orally administered TADIOS mitigated lung injury and neutrophil infiltration. Similar results were obtained in lung tissues to those in RAW264.7 cells, including reduced proinflammatory cytokine production and MPO activity, increased total antioxidant capacity, and upregulated protein levels of HO-1 and Nrf2. The high level of consistency between in vitro and in vivo data suggest that TADIOS may indeed be capable of acting as an effective therapeutics for ARDS. The indications that TADIOS regulates the Nrf2-HO-1 signaling axis, a key pathway against oxidative stress, has significant implications for ARDS. The common denominators of almost all ARDS cases are uncontrolled oxidative stress and inflammation that lead to infiltration of inflammatory cells into the airways, overproduction of proinflammatory cytokines, and in extreme cases, a cytokine storm, all of which eventually cause substantial damage to the lungs (Cheng and Matthay, 2003; Diamond et al., 2020; Gibson et al., 2020; Huppert et al., 2019; Su et al., 2012) . Our data clearly show that TADIOS increased the HO-1 expression by regulating Nrf2, and effectively dealt with excess production of inflammatory mediators and ROS. MAPK/NF-κB signaling pathways, important in the progress of inflammation, may also be regulated by TADIOS. Dioscorea batatas W. Lee et al. Decaisne has been shown to inhibit NF-κB and ERK1/2 in RAW264.7 cells (Jin et al., 2010) , while Taraxacum officinale (L.) Weber ex F.H. Wigg has been reported to reduce oxidative damage via the Nrf2-MAPK-HO-1 signaling pathway . On the other hand, treatment with Schizonepeta tenuifolia (Benth.) Briquet extract suppressed collagen stimulated platelet function by inhibiting MAPK phosphorylation (Jeon et al., 2019) . Data from our own experiments involving RAW264.7 cells also suggested that the LPS-induced activation of MAPK and NF-κB signaling pathways might effectively be inhibited by TADIOS treatment (Fig. S1 ). Taken together, TADIOS is likely to exert effects on inflammation through multiple factors and several different pathways, including Nrf-1, HO-1, MAPK and NF-κB. The active compounds responsible for the observed effects of TADIOS described in this study have not yet been identified. It is likely that the effects of TADIOS are the result of the combined actions of several compounds rather than of one specific molecule. Marker compounds used in this study have already been shown to control the expression of pro-inflammatory cytokines (for allantoin and luteolin-3 ′glucuronide) and HO-1 (for chicoric acid) (Florentino et al., 2016; Kitakaze et al., 2020; Liu et al., 2017) . In addition, the three plants that make up TADIOS also contain a variety of flavonoid and steroidal saponins, which have been reported to exhibit anti-inflammatory and antioxidant properties (Chen et al., 2016; Erden Inal et al., 2001; Kim et al., 2010; Qin et al., 2014; Wu et al., 2020; Yang et al., 2017) . Given the potential for the highly effective therapeutic effects and relevant biological activities of TADIOS observed in this study, further experimentation is warranted to identify active compounds, or to obtain a fraction containing concentrated bioactivity from this botanical extract. It is remarkable that TADIOS works effectively in such a rapidly progressing LPS-induced lung injury model. In this model, 4-6 h after LPS injection, the degree of inflammatory cell infiltration, as measured in the BALF, is greatly increased, and hemorrhagic lung injury is aggravated over time, with its damage level reaching a plateau after 24 h (Asti et al., 2000) . In our experiments, mice were orally administered to 1 h before LPS treatment, and effects in the lungs were analyzed 24 h after LPS introduction. This suggests that the effects of TADIOS observed in this study were the result of TADIOS's activity during that 24-h period. When TADIOS is considered for human use, this could have significant consequences. Many of the infection cases of SARS-CoV-2 are discovered in the relatively early asymptomatic stage, owing to the intensive surveillance systems adopted by most developed nations (Gao et al., 2020) . With TADIOS's ability to do effective work in such a rapidly progressing lung injury model, it is a logical next step to consider the feasibility of this botanical product being administered immediately upon positive diagnosis of the virus to test whether it can inhibit further disease progression. We are currently exploring the feasibility of conducting such a human study using TADIOS for SARS-CoV-2 infection. Our findings clearly indicate that TADIOS effectively alleviates LPSinduced ALI by exerting potent anti-inflammatory and anti-oxidative stress activities via regulation of the Nrf2-HO-1 signaling pathways. The safety and effectiveness of the three plants used for the preparation of TADIOS have been well established throughout their long history of use in Asian countries, particularly to improve respiratory health. Taken together, TADIOS may have the potential to be developed as a safe and This research was supported by Helixmith Co., Ltd. Lipopolysaccharide-induced lung injury in mice. I. Concomitant evaluation of inflammatory cells and haemorrhagic lung damage CD11c+ alveolar macrophages are a source of IL-23 during lipopolysaccharide-induced acute lung injury Schizonepeta tenuifolia ethanol extract exerts anti-inflammatory activity through the inhibition of TLR4 signaling in lipopolysaccharide-stimulated macrophage cells A comprehensive study of the aerial parts of Lonicera japonica Thunb. based on metabolite profiling coupled with PLS-DA Lycium barbarum polysaccharide protects against LPS-induced ARDS by inhibiting apoptosis, oxidative stress, and inflammation in pulmonary endothelial cells Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome Acute lung injury and the acute respiratory distress syndrome Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide Suppressive effects of PG201, an antiarthritic botanical formulation, on lipopolysaccharide-induced inflammatory mediators in Raw264.7 cells The roots of Ilex asprella extract lessens acute respiratory distress syndrome in mice induced by influenza virus Early and late pulmonary effects of nebulized LPS in mice: an acute lung injury model Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection Acute Respiratory Distress Syndrome (ARDS) Accelerated inflammation and oxidative stress induced by LPS in acute lung injury: iotanhibition by ST1926 Beneficial effects of quercetin on oxidative stress induced by ultraviolet A COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Antinociceptive and antiinflammatory effects of Memora nodosa and allantoin in mice Schizonepeta tenuifolia: chemistry, pharmacology, and clinical applications A systematic review of asymptomatic infections with COVID-19 Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS The acute respiratory distress syndrome: mechanisms and perspective therapeutic approaches Ethanol extract of Alismatis Rhizoma reduces acute lung inflammation by suppressing NF-kappaB and activating Nrf2 The acute respiratory distress syndrome: from mechanism to translation Review of the domestic research trends in the study of Korean herbal medicine with anti-inflammation effects Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS Pathogenesis of acute respiratory distress syndrome Schizonepeta tenuifolia inhibits collagen stimulated platelet function via suppressing MAPK and Akt signaling Activation of the Nrf2/HO-1 signaling pathway contributes to the protective effects of baicalein against oxidative stress-induced DNA damage and apoptosis in HEI193 Schwann cells Antiinflammatory activity of bark of Dioscorea batatas DECNE through the inhibition of iNOS and COX-2 expressions in RAW264.7 cells via NF-kappaB and ERK1/2 inactivation Development of transgenic Brassica juncea lines for reduced seed sinapine content by perturbing phenylpropanoid pathway genes Herbology(本草學). Younlimsa Corticosteroids and ARDS: a review of treatment and prevention evidence Chrysoeriol isolated from Eurya cilliata leaves protects MC3T3-E1 cells against hydrogen peroxide-induced inhibition of osteoblastic differentiation Low dose of luteolin activates Nrf2 in the liver of mice at start of the active phase but not that of the inactive phase Higher level of neutrophil-tolymphocyte is associated with severe COVID-19 Tissue damage from neutrophil-induced oxidative stress in COVID-19 1-Palmitoyl-2-Linoleoyl-3-Acetyl-rac-Glycerol (PLAG) rapidly resolves LPS-induced acute lung injury through the effective control of neutrophil recruitment Efficacy and safety of HX 110-A and HX 110-B in promoting respiratory health: protocol for an 8-week, randomized, double-blind, parallel group, placebo-controlled trial Inhibitory effects of compounds isolated from Dioscorea batatas Decne peel on particulate matter-induced pulmonary injury in mice Water-soluble extract from actinidia arguta (siebold & zucc.) planch. Ex miq. And perilla frutescens (L.) britton, ACTPER, ameliorates a dry skin-induced itch in a mice model and promotes filaggrin expression by activating the AhR signaling in HaCaT cells Dehydrodiconiferyl alcohol inhibits osteoclast differentiation and ovariectomyinduced bone loss through acting as an estrogen receptor agonist Dehydrodiconiferyl alcohol promotes BMP-2-induced osteoblastogenesis through its agonistic effects on estrogen receptor Acute respiratory failure in COVID-19: is it "typical Taraxacum officinale protects against lipopolysaccharide-induced acute lung injury in mice Chicoric acid ameliorates lipopolysaccharide-induced oxidative stress via promoting the Keap1/Nrf2 transcriptional signaling pathway in BV-2 microglial cells and mouse brain Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism Effects of Rhizome extract of Dioscorea batatas and its active compound, allantoin, on the regulation of myoblast differentiation and mitochondrial biogenesis in C2C12 myotubes Role of nrf2 in oxidative stress and toxicity The acute respiratory distress syndrome: pathogenesis and treatment Phytochemical and pharmacological profiles of Dioscorea species in Korea Alternative and Natural therapies for acute lung injury and acute respiratory distress syndrome Neutrophils in the initiation and resolution of acute pulmonary inflammation: understanding biological function and therapeutic potential Vaspin protects against LPSinduced ARDS by inhibiting inflammation, apoptosis and reactive oxygen species generation in pulmonary endothelial cells via the Akt/ GSK3beta pathway Dioscin prevents the mitochondrial apoptosis and attenuates oxidative stress in cardiac H9c2 cells Acute lung injury induced by lipopolysaccharide is independent of complement activation Advances in understanding of the pathogenesis of acute respiratory distress syndrome Acute respiratory distress syndrome and lung injury: pathogenetic mechanism and therapeutic implication Nrf2, the master regulator of anti-oxidative responses Rapid characterization of chemical constituents of Platycodon grandiflorum and its adulterant Adenophora stricta by UPLC-QTOF-MS/MS Excessive neutrophils and neutrophil extracellular traps in COVID-19 Chrysoeriol ameliorates TPAinduced acute skin inflammation in mice and inhibits NF-kappaB and STAT3 pathways The implication of oxidative stress and AMPK-nrf2 antioxidative signaling in pneumonia pathogenesis Dioscin relieves endotoxemia induced acute neuro-inflammation and protect neurogenesis via improving 5-HT metabolism Alleviated oxidative damage by Taraxacum officinale through the induction of nrf2-MAPK/PI3K mediated HO-1 activation in murine macrophages RAW 264.7 cell line ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway Supplementary data to this article can be found online at https://doi. org/10.1016/j.jep.2021.113795.